Using paper chart based clinical reminders to improve guideline adherence to lipid management
Rationale, aims and objectives The objective of this study was to apply a paper‐based clinical reminder to improve the adherence to lipid guidelines. Methods Patients with coronary heart disease (CHD) without lipid‐lowering therapy (LLT) were recruited, and medical records were reviewed. Eligible...
Saved in:
Published in | Journal of evaluation in clinical practice Vol. 14; no. 5; pp. 861 - 866 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.10.2008
|
Subjects | |
Online Access | Get full text |
ISSN | 1356-1294 1365-2753 1365-2753 |
DOI | 10.1111/j.1365-2753.2008.01066.x |
Cover
Loading…
Abstract | Rationale, aims and objectives The objective of this study was to apply a paper‐based clinical reminder to improve the adherence to lipid guidelines.
Methods Patients with coronary heart disease (CHD) without lipid‐lowering therapy (LLT) were recruited, and medical records were reviewed. Eligible subjects were randomized; a clinical reminder stating current standards and local insurance policy was stamped on the paper chart in the study group but not in the control. The primary outcome was new LLT subscription in the 6‐month follow‐up period, and the secondary end point was the composite result of LLT or lipid profile check‐up.
Results Ninety‐two patients were assigned to the study group and 102 to the control group. The primary outcome showed no difference at the end of 6 months (OR: 1.70, P = 0.248, 95% CI: 0.69–4.19). The secondary end point was significantly higher in the reminder group (OR: 2.81, P = 0.001, 95% CI: 1.57–5.04).
Conclusion A paper chart based clinical reminder providing update clinical recommendations could modify the doctor's behaviour and improve the attention to lipid levels. However, its effect cannot be transformed into an increase in LLT or a decrease in low‐density lipoprotein level owing to local policy constraint. |
---|---|
AbstractList | The objective of this study was to apply a paper-based clinical reminder to improve the adherence to lipid guidelines.
Patients with coronary heart disease (CHD) without lipid-lowering therapy (LLT) were recruited, and medical records were reviewed. Eligible subjects were randomized; a clinical reminder stating current standards and local insurance policy was stamped on the paper chart in the study group but not in the control. The primary outcome was new LLT subscription in the 6-month follow-up period, and the secondary end point was the composite result of LLT or lipid profile check-up.
Ninety-two patients were assigned to the study group and 102 to the control group. The primary outcome showed no difference at the end of 6 months (OR: 1.70, P = 0.248, 95% CI: 0.69-4.19). The secondary end point was significantly higher in the reminder group (OR: 2.81, P = 0.001, 95% CI: 1.57-5.04).
A paper chart based clinical reminder providing update clinical recommendations could modify the doctor's behaviour and improve the attention to lipid levels. However, its effect cannot be transformed into an increase in LLT or a decrease in low-density lipoprotein level owing to local policy constraint. The objective of this study was to apply a paper-based clinical reminder to improve the adherence to lipid guidelines.RATIONALE, AIMS AND OBJECTIVESThe objective of this study was to apply a paper-based clinical reminder to improve the adherence to lipid guidelines.Patients with coronary heart disease (CHD) without lipid-lowering therapy (LLT) were recruited, and medical records were reviewed. Eligible subjects were randomized; a clinical reminder stating current standards and local insurance policy was stamped on the paper chart in the study group but not in the control. The primary outcome was new LLT subscription in the 6-month follow-up period, and the secondary end point was the composite result of LLT or lipid profile check-up.METHODSPatients with coronary heart disease (CHD) without lipid-lowering therapy (LLT) were recruited, and medical records were reviewed. Eligible subjects were randomized; a clinical reminder stating current standards and local insurance policy was stamped on the paper chart in the study group but not in the control. The primary outcome was new LLT subscription in the 6-month follow-up period, and the secondary end point was the composite result of LLT or lipid profile check-up.Ninety-two patients were assigned to the study group and 102 to the control group. The primary outcome showed no difference at the end of 6 months (OR: 1.70, P = 0.248, 95% CI: 0.69-4.19). The secondary end point was significantly higher in the reminder group (OR: 2.81, P = 0.001, 95% CI: 1.57-5.04).RESULTSNinety-two patients were assigned to the study group and 102 to the control group. The primary outcome showed no difference at the end of 6 months (OR: 1.70, P = 0.248, 95% CI: 0.69-4.19). The secondary end point was significantly higher in the reminder group (OR: 2.81, P = 0.001, 95% CI: 1.57-5.04).A paper chart based clinical reminder providing update clinical recommendations could modify the doctor's behaviour and improve the attention to lipid levels. However, its effect cannot be transformed into an increase in LLT or a decrease in low-density lipoprotein level owing to local policy constraint.CONCLUSIONA paper chart based clinical reminder providing update clinical recommendations could modify the doctor's behaviour and improve the attention to lipid levels. However, its effect cannot be transformed into an increase in LLT or a decrease in low-density lipoprotein level owing to local policy constraint. Rationale, aims and objectives The objective of this study was to apply a paper‐based clinical reminder to improve the adherence to lipid guidelines. Methods Patients with coronary heart disease (CHD) without lipid‐lowering therapy (LLT) were recruited, and medical records were reviewed. Eligible subjects were randomized; a clinical reminder stating current standards and local insurance policy was stamped on the paper chart in the study group but not in the control. The primary outcome was new LLT subscription in the 6‐month follow‐up period, and the secondary end point was the composite result of LLT or lipid profile check‐up. Results Ninety‐two patients were assigned to the study group and 102 to the control group. The primary outcome showed no difference at the end of 6 months (OR: 1.70, P = 0.248, 95% CI: 0.69–4.19). The secondary end point was significantly higher in the reminder group (OR: 2.81, P = 0.001, 95% CI: 1.57–5.04). Conclusion A paper chart based clinical reminder providing update clinical recommendations could modify the doctor's behaviour and improve the attention to lipid levels. However, its effect cannot be transformed into an increase in LLT or a decrease in low‐density lipoprotein level owing to local policy constraint. Rationale, aims and objectives The objective of this study was to apply a paper‐based clinical reminder to improve the adherence to lipid guidelines. Methods Patients with coronary heart disease (CHD) without lipid‐lowering therapy (LLT) were recruited, and medical records were reviewed. Eligible subjects were randomized; a clinical reminder stating current standards and local insurance policy was stamped on the paper chart in the study group but not in the control. The primary outcome was new LLT subscription in the 6‐month follow‐up period, and the secondary end point was the composite result of LLT or lipid profile check‐up. Results Ninety‐two patients were assigned to the study group and 102 to the control group. The primary outcome showed no difference at the end of 6 months (OR: 1.70, P = 0.248, 95% CI: 0.69–4.19). The secondary end point was significantly higher in the reminder group (OR: 2.81, P = 0.001, 95% CI: 1.57–5.04). Conclusion A paper chart based clinical reminder providing update clinical recommendations could modify the doctor's behaviour and improve the attention to lipid levels. However, its effect cannot be transformed into an increase in LLT or a decrease in low‐density lipoprotein level owing to local policy constraint. |
Author | Li, Ai-Tzu Hung, Chi-Sheng Lin, Jou-Wei Hwang, Juey-Jen Tsai, Ru-Yi |
Author_xml | – sequence: 1 givenname: Chi-Sheng surname: Hung fullname: Hung, Chi-Sheng organization: Attending cardiologist – sequence: 2 givenname: Jou-Wei surname: Lin fullname: Lin, Jou-Wei organization: Attending cardiologist – sequence: 3 givenname: Juey-Jen surname: Hwang fullname: Hwang, Juey-Jen organization: Professor – sequence: 4 givenname: Ru-Yi surname: Tsai fullname: Tsai, Ru-Yi organization: Registered nurse, Cardiovascular Center, National Taiwan University Hospital Yun-Lin Branch, Dou-Liou City, Yun-Lin, Taiwan – sequence: 5 givenname: Ai-Tzu surname: Li fullname: Li, Ai-Tzu email: irisli@ccu.edu.tw organization: Assistant Professor, Department and Institute of Adult and Continuing Education, National Chung-Cheng University, Min-Hsiung, Chia-Yi, Taiwan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19018919$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUtv1DAUhS1URB_wF5BX7BLsiZ8LkFBVCqiCWRRmhSzHvjP1kDjBzsD03-MwZRZswBtf6Z7v-vqcc3QShwgIYUpqWs7LbU0bwauF5E29IETVhBIh6v0jdHZsnMw1FxVdaHaKznPeEkIbwuUTdEo1oUpTfYa-fs4hbvBoR0jY3dk04dZm8Nh1IQZnO5ygD9FDyngacOjHNPwAvNkFD0UB2Po7SBAdzO0ujMHj3ka7gR7i9BQ9Xtsuw7OH-wLdvr26vXxX3Xy6fn_55qZyTFJROem0VLRRzjEAJ6zgLTDNy5a8ZZqpxnnfMrJuuZOKMSssAetbqYSzmjYX6MVhbFnu-w7yZPqQHXSdjTDsshFaUc4WpAifPwh3bQ_ejCn0Nt2bP34UweuDwKUh5wRr48JkpzDEKdnQGUrMHIDZmtlnM_ts5gDM7wDMvgxQfw04vvFv9NUB_Rk6uP9vzny4Ws5V4asDH_IE-yNv0zcjZCO5WX28Lj9dyZX8sjTL5hduCa0Y |
CitedBy_id | crossref_primary_10_1136_bmjopen_2017_018271 crossref_primary_10_1093_fampra_cmt080 crossref_primary_10_1097_NNA_0b013e31824ccd0a crossref_primary_10_1371_journal_pone_0110619 crossref_primary_10_1186_s13012_021_01108_0 crossref_primary_10_1002_14651858_CD001174_pub4 crossref_primary_10_2196_60326 crossref_primary_10_1253_circrep_CR_21_0165 crossref_primary_10_1111_j_1365_2753_2008_01094_x |
Cites_doi | 10.1056/NEJM199511163332001 10.1016/j.amjcard.2004.11.051 10.1016/S0140-6736(03)13636-7 10.1111/j.1525-1497.2005.00268.x 10.1161/01.CIR.0000020190.45892.75 10.1161/01.CIR.0000070952.08969.5B 10.1136/bmj.38398.500764.8F 10.7326/0003-4819-136-8-200204160-00005 10.2165/00044011-200727090-00006 10.1111/j.1532-5415.1999.tb07233.x 10.1592/phco.21.9.818.34563 10.1016/j.ijcard.2003.11.002 |
ContentType | Journal Article |
Copyright | 2008 The Authors. Journal compilation © 2008 Blackwell Publishing Ltd |
Copyright_xml | – notice: 2008 The Authors. Journal compilation © 2008 Blackwell Publishing Ltd |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1111/j.1365-2753.2008.01066.x |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2753 |
EndPage | 866 |
ExternalDocumentID | 19018919 10_1111_j_1365_2753_2008_01066_x JEP1066 ark_67375_WNG_19W7W7VP_P |
Genre | article Randomized Controlled Trial Journal Article |
GeographicLocations | Taiwan |
GeographicLocations_xml | – name: Taiwan |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OB 1OC 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABIVO ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACGOF ACMXC ACPOU ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F D-I DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EAD EAP EAS EBB EBC EBD EBS EBX EJD EMB EMK EMOBN EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK0 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACUHS ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY |
ID | FETCH-LOGICAL-c4716-c7c978138cc4eec6a65be4959015b49483cddb40fb5c7844a6a0eadb786ca913 |
IEDL.DBID | DR2 |
ISSN | 1356-1294 1365-2753 |
IngestDate | Fri Jul 11 05:26:42 EDT 2025 Thu May 22 04:42:31 EDT 2025 Thu Apr 24 22:51:54 EDT 2025 Tue Jul 01 04:01:54 EDT 2025 Wed Jan 22 16:27:24 EST 2025 Wed Oct 30 09:57:10 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4716-c7c978138cc4eec6a65be4959015b49483cddb40fb5c7844a6a0eadb786ca913 |
Notes | ark:/67375/WNG-19W7W7VP-P ArticleID:JEP1066 istex:3417B1E6BCF294C834D89219B1CE724ED238979F ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
PMID | 19018919 |
PQID | 69815420 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_69815420 pubmed_primary_19018919 crossref_citationtrail_10_1111_j_1365_2753_2008_01066_x crossref_primary_10_1111_j_1365_2753_2008_01066_x wiley_primary_10_1111_j_1365_2753_2008_01066_x_JEP1066 istex_primary_ark_67375_WNG_19W7W7VP_P |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2008-10 October 2008 2008-10-00 2008-Oct 20081001 |
PublicationDateYYYYMMDD | 2008-10-01 |
PublicationDate_xml | – month: 10 year: 2008 text: 2008-10 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: England |
PublicationTitle | Journal of evaluation in clinical practice |
PublicationTitleAlternate | J Eval Clin Pract |
PublicationYear | 2008 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | Nakagawa, T. , Kobayashi, T. , Awata, N. , et al. (2004) Randomized, controlled trial of secondary prevention of coronary sclerosis in normocholesterolemic patients using pravastatin: final 5-year angiographic follow-up of the Prevention of Coronary Sclerosis (PCS) study. International Journal of Cardiology, 97 (1), 107-114. Lester, W. T. , Grant, R. W. , Barnett, G. O. & Chueh, H. C. (2006) Randomized controlled trial of an informatics-based intervention to increase statin prescription for secondary prevention of coronary disease. Journal of General Internal Medicine, 21 (1), 22-29. Nag, S. S. , Pearson, T. A. , Ma, L. , Landsman, P. B. , Cimino, A. , Vickers, F. F. , Alexander, C. M. & Melin, J. M. (2005) Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease. The American Journal of Cardiology, 95 (7), 862-864. Straka, R. J. , Taheri, R. , Cooper, S. L. , Tan, A. W. & Smith, A. C. (2001) Assessment of hypercholesterolemia control in a managed care organization. Pharmacotherapy, 21 (7), 818-827. Saaddine, J. B. , Engelgau, M. M. , Beckles, G. L. , Gregg, E. W. , Thompson, T. J. & Narayan, K. M. (2002) A diabetes report card for the United States: quality of care in the 1990s. Annals of Internal Medicine, 136 (8), 565-574. Pearson, T. A. , Blair, S. N. , Daniels, S. R. , et al. (2002) Guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation, 106 (3), 388-391. Kawamoto, K. , Houlihan, C. A. , Balas, E. A. & Lobach, D. F. (2005) Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ, 330 (7494), 765. Kell, S. H. , Drass, J. , Bausell, R. B. , Thomas, K. A. , Osborn, M. A. & Gohdes, D. (1999) Measures of disease control in Medicare beneficiaries with diabetes mellitus. Journal of the American Geriatrics Society, 47 (4), 417-422. Scandinavian Simvastatin Study (4S) (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 344 (8934), 1383-1389. Ansari, M. , Shlipak, M. G. , Heidenreich, P. A. , Van Ostaeyen, D. , Pohl, E. C. , Browner, W. S. & Massie, B. M. (2003) Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation, 107 (22), 2799-2804. Paragh, G. , Márk, L. , Zámolyi, K. , Pados, G. & Ofner, P. (2007) Lipid-modifying therapy and attainment of cholesterol goals in Hungary: the return on expenditure achieved for lipid therapy (REALITY) study. Clinical Drug Investigation, 27 (9), 647-660. Collins, R. , Armitage, J. , Parish, S. , Sleigh, P. , Peto, R. & Heart Protection Study Collaborative G.roup (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet, 361 (9374), 2005-2016. Shepherd, J. , Cobbe, S. M. , Ford, I. , Isles, C. G. , Lorimer, A. R. , MacFarlane, P. W. , McKillop, J. H. & Packard, C. J. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. The New England Journal of Medicine, 333 (20), 1301-1307. 1994; 344 2004; 97 2003; 107 2005; 330 2006; 21 2002; 136 1999; 47 2002; 106 2005; 95 1995; 333 2003; 361 2001; 21 2007; 27 Scandinavian Simvastatin Study (4S) (e_1_2_6_4_2) 1994; 344 e_1_2_6_8_2 e_1_2_6_7_2 e_1_2_6_9_2 e_1_2_6_3_2 e_1_2_6_6_2 e_1_2_6_5_2 e_1_2_6_12_2 e_1_2_6_13_2 e_1_2_6_2_2 e_1_2_6_10_2 e_1_2_6_11_2 e_1_2_6_14_2 |
References_xml | – reference: Paragh, G. , Márk, L. , Zámolyi, K. , Pados, G. & Ofner, P. (2007) Lipid-modifying therapy and attainment of cholesterol goals in Hungary: the return on expenditure achieved for lipid therapy (REALITY) study. Clinical Drug Investigation, 27 (9), 647-660. – reference: Collins, R. , Armitage, J. , Parish, S. , Sleigh, P. , Peto, R. & Heart Protection Study Collaborative G.roup (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet, 361 (9374), 2005-2016. – reference: Ansari, M. , Shlipak, M. G. , Heidenreich, P. A. , Van Ostaeyen, D. , Pohl, E. C. , Browner, W. S. & Massie, B. M. (2003) Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation, 107 (22), 2799-2804. – reference: Shepherd, J. , Cobbe, S. M. , Ford, I. , Isles, C. G. , Lorimer, A. R. , MacFarlane, P. W. , McKillop, J. H. & Packard, C. J. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. The New England Journal of Medicine, 333 (20), 1301-1307. – reference: Straka, R. J. , Taheri, R. , Cooper, S. L. , Tan, A. W. & Smith, A. C. (2001) Assessment of hypercholesterolemia control in a managed care organization. Pharmacotherapy, 21 (7), 818-827. – reference: Lester, W. T. , Grant, R. W. , Barnett, G. O. & Chueh, H. C. (2006) Randomized controlled trial of an informatics-based intervention to increase statin prescription for secondary prevention of coronary disease. Journal of General Internal Medicine, 21 (1), 22-29. – reference: Pearson, T. A. , Blair, S. N. , Daniels, S. R. , et al. (2002) Guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation, 106 (3), 388-391. – reference: Kawamoto, K. , Houlihan, C. A. , Balas, E. A. & Lobach, D. F. (2005) Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ, 330 (7494), 765. – reference: Saaddine, J. B. , Engelgau, M. M. , Beckles, G. L. , Gregg, E. W. , Thompson, T. J. & Narayan, K. M. (2002) A diabetes report card for the United States: quality of care in the 1990s. Annals of Internal Medicine, 136 (8), 565-574. – reference: Kell, S. H. , Drass, J. , Bausell, R. B. , Thomas, K. A. , Osborn, M. A. & Gohdes, D. (1999) Measures of disease control in Medicare beneficiaries with diabetes mellitus. Journal of the American Geriatrics Society, 47 (4), 417-422. – reference: Nakagawa, T. , Kobayashi, T. , Awata, N. , et al. (2004) Randomized, controlled trial of secondary prevention of coronary sclerosis in normocholesterolemic patients using pravastatin: final 5-year angiographic follow-up of the Prevention of Coronary Sclerosis (PCS) study. International Journal of Cardiology, 97 (1), 107-114. – reference: Scandinavian Simvastatin Study (4S) (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 344 (8934), 1383-1389. – reference: Nag, S. S. , Pearson, T. A. , Ma, L. , Landsman, P. B. , Cimino, A. , Vickers, F. F. , Alexander, C. M. & Melin, J. M. (2005) Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease. The American Journal of Cardiology, 95 (7), 862-864. – volume: 136 start-page: 565 issue: 8 year: 2002 end-page: 574 article-title: A diabetes report card for the United States: quality of care in the 1990s publication-title: Annals of Internal Medicine – volume: 97 start-page: 107 issue: 1 year: 2004 end-page: 114 article-title: Randomized, controlled trial of secondary prevention of coronary sclerosis in normocholesterolemic patients using pravastatin: final 5‐year angiographic follow‐up of the Prevention of Coronary Sclerosis (PCS) study publication-title: International Journal of Cardiology – volume: 344 start-page: 1383 issue: 8934 year: 1994 end-page: 1389 article-title: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) publication-title: Lancet – volume: 106 start-page: 388 issue: 3 year: 2002 end-page: 391 article-title: Guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases publication-title: Circulation – volume: 330 start-page: 765 issue: 7494 year: 2005 article-title: Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success publication-title: BMJ – volume: 95 start-page: 862 issue: 7 year: 2005 end-page: 864 article-title: Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease publication-title: The American Journal of Cardiology – volume: 21 start-page: 22 issue: 1 year: 2006 end-page: 29 article-title: Randomized controlled trial of an informatics‐based intervention to increase statin prescription for secondary prevention of coronary disease publication-title: Journal of General Internal Medicine – volume: 27 start-page: 647 issue: 9 year: 2007 end-page: 660 article-title: Lipid‐modifying therapy and attainment of cholesterol goals in Hungary: the return on expenditure achieved for lipid therapy (REALITY) study publication-title: Clinical Drug Investigation – volume: 21 start-page: 818 issue: 7 year: 2001 end-page: 827 article-title: Assessment of hypercholesterolemia control in a managed care organization publication-title: Pharmacotherapy – volume: 333 start-page: 1301 issue: 20 year: 1995 end-page: 1307 article-title: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia publication-title: The New England Journal of Medicine – volume: 47 start-page: 417 issue: 4 year: 1999 end-page: 422 article-title: Measures of disease control in Medicare beneficiaries with diabetes mellitus publication-title: Journal of the American Geriatrics Society – volume: 361 start-page: 2005 issue: 9374 year: 2003 end-page: 2016 article-title: MRC/BHF Heart Protection Study of cholesterol‐lowering with simvastatin in 5963 people with diabetes: a randomised placebo‐controlled trial publication-title: Lancet – volume: 107 start-page: 2799 issue: 22 year: 2003 end-page: 2804 article-title: Improving guideline adherence: a randomized trial evaluating strategies to increase beta‐blocker use in heart failure publication-title: Circulation – ident: e_1_2_6_3_2 doi: 10.1056/NEJM199511163332001 – ident: e_1_2_6_9_2 doi: 10.1016/j.amjcard.2004.11.051 – ident: e_1_2_6_2_2 doi: 10.1016/S0140-6736(03)13636-7 – volume: 344 start-page: 1383 issue: 8934 year: 1994 ident: e_1_2_6_4_2 article-title: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) publication-title: Lancet – ident: e_1_2_6_11_2 doi: 10.1111/j.1525-1497.2005.00268.x – ident: e_1_2_6_5_2 doi: 10.1161/01.CIR.0000020190.45892.75 – ident: e_1_2_6_14_2 doi: 10.1161/01.CIR.0000070952.08969.5B – ident: e_1_2_6_13_2 doi: 10.1136/bmj.38398.500764.8F – ident: e_1_2_6_7_2 doi: 10.7326/0003-4819-136-8-200204160-00005 – ident: e_1_2_6_10_2 doi: 10.2165/00044011-200727090-00006 – ident: e_1_2_6_6_2 doi: 10.1111/j.1532-5415.1999.tb07233.x – ident: e_1_2_6_8_2 doi: 10.1592/phco.21.9.818.34563 – ident: e_1_2_6_12_2 doi: 10.1016/j.ijcard.2003.11.002 |
SSID | ssj0013057 |
Score | 1.8620714 |
Snippet | Rationale, aims and objectives The objective of this study was to apply a paper‐based clinical reminder to improve the adherence to lipid guidelines.
Methods ... Rationale, aims and objectives The objective of this study was to apply a paper‐based clinical reminder to improve the adherence to lipid guidelines. Methods ... The objective of this study was to apply a paper-based clinical reminder to improve the adherence to lipid guidelines. Patients with coronary heart disease... The objective of this study was to apply a paper-based clinical reminder to improve the adherence to lipid guidelines.RATIONALE, AIMS AND OBJECTIVESThe... |
SourceID | proquest pubmed crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 861 |
SubjectTerms | Aged Attitude of Health Personnel behaviour and behaviour mechanisms Chi-Square Distribution Coronary Disease - diagnosis Coronary Disease - etiology Coronary Disease - prevention & control Decision Support Systems, Clinical Drug Prescriptions - statistics & numerical data Female Follow-Up Studies guideline Guideline Adherence - organization & administration Health Knowledge, Attitudes, Practice HMG-CoA Humans Hyperlipidemias - prevention & control Hypolipidemic Agents - therapeutic use Logistic Models Male Medical Records Practice Guidelines as Topic Practice Patterns, Physicians' - organization & administration Reimbursement, Incentive reminder systems Reminder Systems - instrumentation statins Taiwan |
Title | Using paper chart based clinical reminders to improve guideline adherence to lipid management |
URI | https://api.istex.fr/ark:/67375/WNG-19W7W7VP-P/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-2753.2008.01066.x https://www.ncbi.nlm.nih.gov/pubmed/19018919 https://www.proquest.com/docview/69815420 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEB5EQbz4fqzPHMRbyz6z2WN9VBGUImq9SEiyiZZqW-oWir_ezD6qFQ8i3hbCZDeTmZ2ZZOYbgENqqPS1VUBpXIMtzLAboDE1YTecWfMhfIW1w1fX9OIuvHyIHsr8J6yFKfAhJgduqBn5_xoVXMi3aSUv6qmioEyJtNENraM_iQPoH934nxcKbg766QUIu-cn4XRSz48TTVmqOWT6-Cc3dNqrzc1Scwm61YKKbJRufZTJunr_hvX4PytehsXSeyWNQtxWYEb3VmH-qryfX4PHPAOBDMRADwkWdGUEzWRKqgJMMkQwE0yeJlmfdPITDU2eRgi2ZWcgIn0u6g9x-KUz6KTkdZKgsw63zbPbk4ta2cChpqzNozUVK4TUCphSodaKChpJbSMy9EEk4tIEKk1l6BoZqZiFoaDCtZItY0aVSLxgA2Z7_Z7esnvFvFCIRIogsQG9EswwXxrNolAzE6TMgbjaK65KcHPssfHCvwQ5lnkcmVe23kTm8bED3oRyUAB8_ILmKBeHCYEYdjFBLo54-_qce0k7bsf3Ld5y4KCSF27VFu9iRE_3R2-cJsw6r77rwGYhRp8vt9xhiZc4QHNh-PVX8cuzFj5t_5VwBxb8Cu3X24XZbDjSe9blyuQ-zDWOT4-b-7lSfQB3MhyJ |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9owEB5VILV76faxu832gQ9Vb6A8HedYtVBKAaGKFi4ry3bsFsECYoOE-uvryYMtFQdU9RYpGicZz2TG9sz3AbylhkpfWweUxjVIYYZsgMY0hZ1wZsOH8BX2Dg-GtPst7E2jaUkHhL0wBT7EfsMNPSP_X6OD44b0oZcXDVVRUNZE2uUNbdmEso4E30hn8PGrf3-k4Oawn16AwHt-Eh6W9Rwd6SBW1VHtu2OJ6GFemwemzjksqk8q6lHmrW0mW-rXX2iP_-mbn8DjMoEl7wuLewoP9PIZPByUR_TP4SYvQiBrsdYbgj1dGcFImZKqB5NsEM8E66dJtiKzfFNDkx9bxNuyIxCR_ixaEPH2YraepeR2X6NzAeNOe_yh2yw5HJrKhj3aVLFCVK2AKRVqraigkdR2UYZpiERomkClqQxdIyMVszAUVLjWuGXMqBKJF1xCbbla6hd2spgXCpFIESR2Ta8EM8yXRrMo1MwEKXMgriaLqxLfHGk2FvyPdY5VHkflleybqDy-c8DbS64LjI8TZN7l9rAXEJs51sjFEZ8MP3EvmcST-PuIjxxoVAbDreficYxY6tX2jtOE2fzVdx24Kuzo_uFWOyzxEgdobg0nvxXvtUd4df2vgg141B0P-rz_efjlJZz5Ffiv9wpq2WarX9sMLJNvcs_6DU-uHzE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9swDCaGFih22avr6u5RHYrdEvghy_Jx2Jp13RoEQ7f0UgiSLHVB0sTIHKDYrx_pR7oMPRTDbgYMyjZFmpT08SPAkfDCxA4d0PjQUwsz6gbofU_jhEsMHzq2VDt8NhQn3_jpRXrR4p-oFqbhh1hvuJFn1P9rcvCy8JtO3tRTpUkLicTVjehjPrnNBfoOJUhf49sThbBm_YwS4t2Lc76J6rlzpI1QtU1av7krD91Ma-u4NHgM0-6LGjjKtL-qTN_--ovs8f988hN41Kav7F1jb0_hgZs_g52z9oB-Fy5rCAIrdemWjCq6KkZxsmBdBSZbEpsJoadZtWCTekvDsasVsW3hCEwXP5oCRLo9m5STgl2vETrP4XxwfP7-pNd2cOhZDHqiZzNLnFqJtJY7Z4UWqXG4JKMkxBAxTWKLwvDQm9RmknMtdIimbTIprM6jZA-25ou528e5khHXOjc6yXFFb7X0MjbeyZQ76ZNCBpB1c6Vsy25OTTZm6o9VDipPkfLa3pukPHUTQLSWLBuGj3vIvK3NYS2gl1NCyGWpGg8_qigfZ-Ps-0iNAjjs7EWh39JhjJ67xeqnErnE7DUOA3jRmNHtw1E7Mo_yAERtDPd-K3V6PKKrg38VPISd0YeB-vJp-PklPIw75t_oFWxVy5V7jelXZd7UfvUb4oQd6Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Using+paper+chart+based+clinical+reminders+to+improve+guideline+adherence+to+lipid+management&rft.jtitle=Journal+of+evaluation+in+clinical+practice&rft.au=Hung%2C+Chi-Sheng&rft.au=Lin%2C+Jou-Wei&rft.au=Hwang%2C+Juey-Jen&rft.au=Tsai%2C+Ru-Yi&rft.date=2008-10-01&rft.eissn=1365-2753&rft.volume=14&rft.issue=5&rft.spage=861&rft_id=info:doi/10.1111%2Fj.1365-2753.2008.01066.x&rft_id=info%3Apmid%2F19018919&rft.externalDocID=19018919 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1356-1294&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1356-1294&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1356-1294&client=summon |